Skip to content
Tenfell
Closed tender
Published 24 Apr 2026

Procurement of Direct‑to‑Patient Genetic Testing Service for the NHS Jewish BRCA Programme

NHS England · London

Key facts

Estimated value
£3,733,647
Closing date
19 May 2026
Contract ends
31 Mar 2029
Procedure
Open procedure
Buyer type
Central government

Description

NHS England (NHSE) is procuring a contract with a single lead provider to deliver a direct‑to‑patient (DTP) pathway for genetic testing programmes for high‑risk cohorts, including the NHS Jewish BRCA Testing Programme. This procurement represents a scale‑up of the existing programme. To date, the NHS Jewish BRCA Testing Programme has been delivered through the BRCA‑DIRECT pathway led by the Institute of Cancer Research. BRCA‑DIRECT is an example of a DTP model. Direct‑to‑patient pathways offer a new approach to delivering genetic testing without requiring individuals to attend in‑person appointments. Key features of the DTP model include: - All patient information provided in written format, allowing individuals to review it at a time that suits them - No face‑to‑face appointment required prior to testing - Patient consent captured by post or online - At‑home genetic testing using postal saliva kits - Access to a Genetic Counsellor hotline Full details of the service requirements and specification are included within the ITT pack.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.